Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2025

Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2025

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2025. The cash dividend of $0.24 per share is payable on or about October 31, 2025 to stockholders of record as of the close of business on September 30, 2025 .

About Zimmer Biomet

Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.

With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.

For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X / Twitter at www.twitter.com/zimmerbiomet .

Media


I nvestors

Kristen Cardillo


David DeMartino

925-786-4913


646-531-6115

kristen.cardillo@zimmerbiomet.com


david.demartino@zimmerbiomet.com

Kirsten Fallon


Zach Weiner

781-779-5561


908-591-6955

kirsten.fallon@zimmerbiomet.com


zach.weiner@zimmerbiomet.com




Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/zimmer-biomet-announces-quarterly-dividend-for-third-quarter-of-2025-302539418.html

SOURCE Zimmer Biomet Holdings, Inc.

News Provided by PR Newswire via QuoteMedia

ZBH:US
The Conversation (0)
Zimmer Biomet Holdings Inc.

Zimmer Biomet Holdings Inc.

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Latest Press Releases

Related News

×